EBOS GROUP LIMITED — Director's Dealing 2020

Apr 8, 2020

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		9-Apr-20
Date of last disclosure:		2-Dec-19
Director or senior managergiving disclosure
Full name(s):		Elizabeth Coutts
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):
Position held in listed issuer:		Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinaryshares Nature of the affected relevant interest(s): Issue of shares pursuant to dividend reinvestmentplan For that relevant interest- Number held in class before acquisition or disposal: 32,865 Number held in class after acquisition or disposal: 33,313 Current registered holder(s): N/A Registered holder(s) once transfers are registered: Como Nominees Limited
Class of affected quoted financial products:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to dividend reinvestmentplan
For that relevant interest-
Number held in class before acquisition or disposal:		32,865
Number held in class after acquisition or disposal:		33,313
Current registered holder(s):		N/A
Registered holder(s) once transfers are registered:		Como Nominees Limited

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		3-Apr-20
		Issue of shares pursuant to dividend reinvestmentplan
		N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value,describe the consideration:		$9,076.48
Number of financialproducts to which the transaction related:		448 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:		Ordinaryshares
Nature of relevant interest:		Non-beneficial interest
_For that relevant interest,- _
Number held in class:		71592 ordinaryshares
		Elizabeth Mary Coutts &
		John Matthew Cullity as
		trustees of the EBOS Staff
Current registered holder(s):		Share Plan

The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$9,076.48	$9,076.48
Number of financialproducts to which the transaction related:		448 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:		Ordinaryshares
Nature of relevant interest:		Non-beneficial interest
Number held in class:		71592 ordinaryshares
Current registered holder(s):		Elizabeth Mary Coutts & John Matthew Cullity as trustees of the EBOS Staff Share Plan
For a derivative relevant interest,- Type of derivative: Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:		9-Apr-20
Name and title of authorised person:		Janelle Cain, General Counsel EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		9-Apr-20
Date of last disclosure:		2-Dec-19
Director or senior managergiving disclosure
Full name(s):		Stuart McLauchlan
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to dividend reinvestmentplan
For that relevant interest-
Number held in class before acquisition or disposal:		2,000
Number held in class after acquisition or disposal:		2,037
Current registered holder(s):		N/A
Registered holder(s)once transfers are registered:		JBWere(NZ)Nominees Limited

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		3-Apr-20
		Issue of shares pursuant to dividend reinvestmentplan
		N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$749.62
Number of financialproducts to which the transaction related:		37 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A

Summary of other relevant interests after acquisition or disposal:

Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:		N/A
Nature of relevant interest:		N/A
_For that relevant interest,- _
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financialproducts:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:

Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:		9-Apr-20
Name and title of authorised person:		Janelle Cain, General Counsel, EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		9-Apr-20
Date of last disclosure:		18-Oct-19
Director or senior managergiving disclosure
Full name(s):		Sarah Ottrey
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to dividend reinvestmentplan
For that relevant interest-
Number held in class before acquisition or disposal:		8,268
Number held in class after acquisition or disposal:		8,380
Current registered holder(s):		Sarah Christine Ottrey & Peter Calder Groves
Registered holder(s) once transfers are registered:		Sarah Christine Ottrey & Peter Calder Groves

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

		le)
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:		N/A
For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		3-Apr-20
		Issue of shares pursuant to dividend reinvestmentplan
		N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$2,269.12
Number of financialproducts to which the transaction related:		112 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Ordinary shares Beneficial interest 3050 ordinary shares FNZ Nominees Limited which holds shares on behalf of The Phil Ingham Family Trust N/A N/A N/A N/A N/A N/A N/A N/A N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: 9-Apr-20 Janelle Cain, General Counsel, Name and title of authorised person: EBOS Group Limited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		9-Apr-20
Date of last disclosure:		18-Oct-19
Director or senior managergiving disclosure
Full name(s):		Sean Duggan
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		CEO,Animal Care and Consumer Brands

Summary of acquisition or disposal of relevant interest(excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal:	Summary of acquisition or disposal of relevant interest(excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal:
Class ofaffected quotedfinancialproducts:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to dividend reinvestmentplan
For that relevant interest-
Number held in class before acquisition or disposal:		315
Number held in class after acquisition or disposal:		320
Current registered holder(s):		Sean Duggan
Registeredholder(s) once transfers areregistered:		N/A
Summary of acquisition or disposal of specified derivatives relevant interest(if applicab		le)
Type of affected derivative:		N/A
Class of underlyingfinancialproducts:		N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts:		N/A
_For that derivative,- _
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactionsgiving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
		3-Apr-20
		Issue of shares pursuant to dividend reinvestmentplan
		N/A
		$101.30
		5 ordinaryshares
		No

Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: Nature of relevant interest:

For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

N/A N/A Ordinary shares Registered holder - 2017 long term incentive plan 50,000 ordinary shares Sean Duggan N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

or

or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:		9-Apr-20
Name and title of authorised person:		Janelle Cain, General Counsel, EBOS Group Limited